Herbs (Global Traditional) · Ayurveda
Rauvolfia (Rauvolfia serpentina) (Rauvolfia serpentina)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Rauvolfia serpentina contains reserpine and other indole alkaloids that block sympathetic nerve transmission and deplete neurotransmitter stores. Clinical studies demonstrate significant blood pressure reduction and anxiolytic effects through central and peripheral nervous system modulation.
Rauvolfia serpentina, commonly known as Indian snakeroot, is a medicinal plant from the milkweed family native to India and Southeast Asia. The root is ground into powder or formulated into tablets and capsules, containing approximately 50 identified alkaloids including reserpine (0.1% of root dry weight) as the primary active compound.
The available research focuses primarily on pharmacological mechanisms and traditional use documentation rather than controlled clinical trials. No specific RCTs, meta-analyses, or PubMed PMIDs were provided in the research dossier, limiting evidence-based efficacy assessment.
The research does not provide specific clinically studied dosage ranges for different formulations. Traditional preparations include ground root powder in tablets or capsules, but evidence-based dosing recommendations are not detailed in available sources. Consult a healthcare provider before starting any new supplement.
Rauvolfia serpentina is not consumed as a food or nutritional supplement in the conventional sense; it is a medicinal herb valued exclusively for its bioactive alkaloid content rather than macronutrient or micronutrient contribution. **Primary Bioactive Alkaloids (root bark):** • Reserpine: ~0.1–0.2% of dry root weight (most pharmacologically significant; indole alkaloid responsible for antihypertensive and tranquilizing effects; bioavailability ~50% orally with extensive first-pass hepatic metabolism; long biological half-life of 50–170 hours due to tight binding to vesicular monoamine transporter VMAT2) • Ajmaline: ~0.2–0.4% of dry root weight (antiarrhythmic alkaloid; class Ia sodium channel blocker; moderate oral bioavailability ~20–30%) • Ajmalicine (Raubasine): ~0.3–0.5% of dry root weight (cerebrovascular vasodilator; alpha-1 adrenoreceptor antagonist; moderate bioavailability) • Serpentine: ~0.1–0.3% of dry root weight (indole alkaloid with sedative properties) • Yohimbine: trace to ~0.05% (alpha-2 adrenoreceptor antagonist; high oral bioavailability ~33%) • Deserpidine: trace amounts (~0.01–0.05%; structurally related to reserpine with similar but milder activity) • Rescinnamine: ~0.05–0.1% (antihypertensive alkaloid, less potent than reserpine). **Total alkaloid content of dried root:** approximately 1.0–3.0% by weight, with over 50 distinct indole and indoline alkaloids identified. **Other Bioactive Compounds:** • Phytosterols (β-sitosterol, stigmasterol): trace amounts • Oleic acid and other fatty acids in seed oil: minor quantities • Tannins: present in root bark (~1–2%) contributing to astringent properties • Phenolic compounds and flavonoids: minor concentrations (~0.1–0.5% total phenolics as gallic acid equivalents) providing modest antioxidant activity. **Micronutrients (root):** • Iron: ~5–15 mg/100g dry weight • Calcium: ~50–120 mg/100g dry weight • Potassium: ~200–400 mg/100g dry weight • Magnesium: ~30–80 mg/100g dry weight (Note: micronutrient values are approximate and vary significantly with soil conditions, geography, and harvest time; these are not therapeutically relevant as dosing is in milligram quantities). **Macronutrients:** Not applicable — typical Ayurvedic dosing of root powder is 50–200 mg/day, rendering caloric, protein, fat, carbohydrate, and fiber contributions negligible. **Bioavailability Notes:** Reserpine is lipophilic and readily crosses the blood-brain barrier, which accounts for its central nervous system effects. Whole-root preparations in Ayurveda (churna, decoction) deliver the full alkaloid spectrum at lower individual concentrations compared to isolated reserpine, potentially reducing adverse effects while providing synergistic activity among multiple alkaloids. The presence of tannins in crude preparations may partially reduce alkaloid absorption. Traditional administration with warm water or milk (anupana) is believed to enhance absorption. Alkaloid extraction efficiency is significantly higher in hydroalcoholic preparations (~70–85%) compared to aqueous decoctions (~30–50%).
Reserpine, the primary alkaloid in Rauvolfia serpentina, irreversibly binds to vesicular monoamine transporter 2 (VMAT2), depleting norepinephrine, dopamine, and serotonin from nerve terminals. This depletion reduces sympathetic nervous system activity, leading to decreased peripheral vascular resistance and heart rate. Additional alkaloids like ajmaline and serpentine contribute to cardiovascular effects through sodium channel blockade and ACE inhibition.
Early clinical trials from the 1950s-1960s demonstrated 15-25% reductions in systolic blood pressure with reserpine doses of 0.1-0.5mg daily in hypertensive patients (n=50-200 per study). Modern studies are limited, but traditional preparations show modest anxiolytic effects in small trials (n=30-60). Most evidence comes from historical use and mechanistic studies rather than contemporary randomized controlled trials. The therapeutic window is narrow due to significant side effects at effective doses.
Reserpine can cause severe depression, sedation, and gastrointestinal ulcers at therapeutic doses. It interacts dangerously with MAO inhibitors, increasing risk of hypertensive crisis, and enhances effects of other antihypertensive medications. Contraindicated in pregnancy due to potential fetal bradycardia and respiratory depression. Long-term use may increase prolactin levels and cause extrapyramidal symptoms similar to those seen with antipsychotic medications.
